View in EDS HTML Full Text PDF Full Text

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.

Saved in:
Bibliographic Details
Title: High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
Authors: Jank P; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany., Leichsenring J; Institute of Pathology, Zytologie Und Molekulare Diagnostik, REGIOMED, Klinikum Coburg, Coburg, Germany., Kolb S; Department of Gynecology, Vivantes Netzwerk Für Gesundheit GmbH Berlin, Vivantes Hospital Neukölln, Rudower Straße 48, 12351, Berlin, Germany., Hoffmann I; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany., Bischoff P; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany., Kunze CA; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany., Dragomir MP; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany., Gleitsmann M; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany., Jesinghaus M; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany., Schmitt WD; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany., Kulbe H; Tumorbank Ovarian Cancer Network, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Sers C; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Sehouli J; Tumorbank Ovarian Cancer Network, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Braicu IE; Tumorbank Ovarian Cancer Network, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Westhoff C; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany., Horst D; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany., Denkert C; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany., Gröschel S; Oncology Center Worms, Worms, Germany., Taube ET; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany. eliane.taube@charite.de.
Source: Journal of ovarian research [J Ovarian Res] 2023 Jul 31; Vol. 16 (1), pp. 150. Date of Electronic Publication: 2023 Jul 31.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101474849 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-2215 (Electronic) Linking ISSN: 17572215 NLM ISO Abbreviation: J Ovarian Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37525239
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jank+P%22">Jank P</searchLink>; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Leichsenring+J%22">Leichsenring J</searchLink>; Institute of Pathology, Zytologie Und Molekulare Diagnostik, REGIOMED, Klinikum Coburg, Coburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kolb+S%22">Kolb S</searchLink>; Department of Gynecology, Vivantes Netzwerk Für Gesundheit GmbH Berlin, Vivantes Hospital Neukölln, Rudower Straße 48, 12351, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+I%22">Hoffmann I</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bischoff+P%22">Bischoff P</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kunze+CA%22">Kunze CA</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Dragomir+MP%22">Dragomir MP</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Gleitsmann+M%22">Gleitsmann M</searchLink>; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Jesinghaus+M%22">Jesinghaus M</searchLink>; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+WD%22">Schmitt WD</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kulbe+H%22">Kulbe H</searchLink>; Tumorbank Ovarian Cancer Network, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Sers+C%22">Sers C</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Stenzinger+A%22">Stenzinger A</searchLink>; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Sehouli+J%22">Sehouli J</searchLink>; Tumorbank Ovarian Cancer Network, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Braicu+IE%22">Braicu IE</searchLink>; Tumorbank Ovarian Cancer Network, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Westhoff+C%22">Westhoff C</searchLink>; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Horst+D%22">Horst D</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Denkert+C%22">Denkert C</searchLink>; Institute of Pathology, Philipps-University Marburg, University Hospital Marburg (UKGM), Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Gröschel+S%22">Gröschel S</searchLink>; Oncology Center Worms, Worms, Germany.<br /><searchLink fieldCode="AU" term="%22Taube+ET%22">Taube ET</searchLink>; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, CCM, Charitéplatz 1, 10117, Berlin, Germany. eliane.taube@charite.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101474849%22">Journal of ovarian research</searchLink> [J Ovarian Res] 2023 Jul 31; Vol. 16 (1), pp. 150. <i>Date of Electronic Publication: </i>2023 Jul 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101474849 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-2215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217572215%22">17572215 </searchLink><i>NLM ISO Abbreviation: </i>J Ovarian Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37525239
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13048-023-01239-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 150
    Titles:
      – TitleFull: High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jank P
      – PersonEntity:
          Name:
            NameFull: Leichsenring J
      – PersonEntity:
          Name:
            NameFull: Kolb S
      – PersonEntity:
          Name:
            NameFull: Hoffmann I
      – PersonEntity:
          Name:
            NameFull: Bischoff P
      – PersonEntity:
          Name:
            NameFull: Kunze CA
      – PersonEntity:
          Name:
            NameFull: Dragomir MP
      – PersonEntity:
          Name:
            NameFull: Gleitsmann M
      – PersonEntity:
          Name:
            NameFull: Jesinghaus M
      – PersonEntity:
          Name:
            NameFull: Schmitt WD
      – PersonEntity:
          Name:
            NameFull: Kulbe H
      – PersonEntity:
          Name:
            NameFull: Sers C
      – PersonEntity:
          Name:
            NameFull: Stenzinger A
      – PersonEntity:
          Name:
            NameFull: Sehouli J
      – PersonEntity:
          Name:
            NameFull: Braicu IE
      – PersonEntity:
          Name:
            NameFull: Westhoff C
      – PersonEntity:
          Name:
            NameFull: Horst D
      – PersonEntity:
          Name:
            NameFull: Denkert C
      – PersonEntity:
          Name:
            NameFull: Gröschel S
      – PersonEntity:
          Name:
            NameFull: Taube ET
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 07
              Text: 2023 Jul 31
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1757-2215
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of ovarian research
              Type: main
ResultId 1